EN DE
Watch Citra Marga Nusaphala Persada for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Citra Marga Nusaphala Persada (CMNP) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Citra Marga Nusaphala Persada stock IDR 2,818, price IDR 1,265, upside +122.8%, quality 47 out of 100. Rating: strongly undervalued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Industrials ID · ISIN ID1000070402

CM Citra Marga Nusaphala Persada logo Thin data Nov 5, 2026

Citra Marga Nusaphala Persada

CMNP · JK
Cheap, value-trap risk

The stock costs 55% less than our calculation considers fair.

Fair value 2,818 IDR · Strongly undervalued (55%)
Healthy Growth (revenue YoY +41.3 %/yr in IDR)
Solidly profitable · 13.4% net margin (TTM)
Low debt
Generates free cash flow
Ranks above peers (11/13)
Revenue last quarter +72% vs. a year ago.
Quality 47/100
Moderate moat 54/100 · thin data
Thin data
Watch Citra Marga Nusaphala Persada for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

3,970 IDR 1,195 IDR Fair Value 2,818 IDR Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.

How to read this chart

60‑month range 1,195 IDR – 3,970 IDR · fair‑value band 1,297 IDR – 4,326 IDR · the 1,265 IDR price screens below the 2,818 IDR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.

Follow Citra Marga Nusaphala Persada in your weekly email

Every Wednesday you see whether Citra Marga Nusaphala Persada is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

PT Citra Marga Nusaphala Persada Tbk, together with its subsidiaries, constructs, operates, and maintains toll roads in Indonesia. It provides trade, development, procurement, contractors, industry, land management, toll road support, and other services.

Show moreShow less

The company was founded in 1987 and is headquartered in Jakarta Utara, Indonesia.

Stock analysis

Citra Marga Nusaphala Persada (CMNP) currently trades at 1,265 IDR, while our model-based Fair Value estimate is 2,818 IDR, implying the stock looks roughly 55% undervalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 3,659 IDR per share, and 19 of the 22 models we run sit above the 1,265 IDR price.

Bear case: the Economic Profit group reads lowest at 1,265 IDR, and 3 of the 22 models stay below the price. Data coverage for this calculation is low.

Scenario range: 1,297 IDR (bear) to 4,326 IDR (bull), the price of 1,265 IDR sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 47/100 (below-average quality), in the Industrials sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Citra Marga Nusaphala Persada reported revenue of 5.8T IDR in FY2025 versus 4.4T IDR in FY2021, a compound +6.9%/yr. Reported net income was 1.0T IDR in FY2025, compounding +8.9%/yr from FY2021.

Key figures

Market cap 8.0T IDR (≈ $442M) Small · P/E ratio 8.8 · P/S ratio 1.22 · EPS (TTM) 143.00 IDR · Net margin 13.4% · Return on equity 4.7% · Return on assets (EBIT) 6.9% (5-year average) · Operating margin 24.6%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 54 out of 100 (low confidence).

What moves the price

The share trades about 35% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at 9% fair-value upside, at 123%, CMNP screens cheaper than that median.

Fair Value models

Bear 1,297 IDR Fair Value 2,818 IDR Bull 4,326 IDR
Price 1,265 IDR · Upside +122.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (122.24 IDR per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Growth DCF 1,141 IDR 2,506 IDR 4,326 IDR 75
FCF DCF 1,208 IDR 2,477 IDR 5,266 IDR 74
EPV 692.04 IDR 870.15 IDR 1,016 IDR 74
All 22 models by family
DCF Models
FCF DCF 1,208 IDR 2,477 IDR 5,266 IDR 74
Owner Earnings 1,717 IDR 3,680 IDR 6,869 IDR 72
5Y Revenue Exit 673.65 IDR 1,671 IDR 3,044 IDR 68
5Y EBITDA Exit 1,605 IDR 3,732 IDR 6,543 IDR 71
5Y P/E Exit 1,414 IDR 3,311 IDR 5,605 IDR 68
10Y Revenue Exit 822.06 IDR 1,806 IDR 3,372 IDR 63
10Y EBITDA Exit 1,411 IDR 3,184 IDR 6,122 IDR 64
10Y P/E Exit 1,297 IDR 2,903 IDR 5,384 IDR 60
Earnings-Based
Graham-Dodd 1,054 IDR 6,151 IDR 8,561 IDR 63
Lynch FV 1,741 IDR 2,487 IDR 3,233 IDR 61
PEG = 1.0 1,741 IDR 2,487 IDR 3,233 IDR 57
EPV 692.04 IDR 870.15 IDR 1,016 IDR 74
Multiples
P/E Multiple 2,440 IDR 3,254 IDR 4,067 IDR 63
P/S Multiple 1,300 IDR 1,733 IDR 2,167 IDR 58
EV/EBIT 2,208 IDR 3,234 IDR 4,260 IDR 65
EV/EBITDA 1,896 IDR 2,818 IDR 3,740 IDR 66
EV/Revenue 221.37 IDR 689.34 IDR 1,157 IDR 49
Growth DCF
Growth DCF 1,141 IDR 2,506 IDR 4,326 IDR 75
Rev-Margin DCF 673.65 IDR 1,651 IDR 3,010 IDR 68
Economic Profit
Residual Income 1,634 IDR 1,659 IDR 1,780 IDR 71
ROIC Compounder 692.04 IDR 870.15 IDR 1,016 IDR 72
Growth Earnings
Growth-Adj P/E 2,561 IDR 3,659 IDR 4,756 IDR 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 47/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 33
How much profit the company makes from its sales and capital
Quality Growth 44
Are margins and returns getting better?
Cashflow 62
Do the profits arrive as real cash?
Financial strength 42
Debt, balance sheet and risk of trouble
Investment 57
Does it invest with discipline instead of growing at any price?
Low Volatility 71
How calm the share price moves, does not count
Price momentum 30
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 13
Distance to the 52-week high, does not count
New shares 41
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
What shareholders gained per year (last 5 years), in IDR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in IDR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+4.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.4%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.4.4% vs 3.3%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.30% → 28%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+9.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Indonesia: IMF forecast 2.6% a year to 2030, 2.9% from 2016 to 2025) that is about +6.7% a year for the price.

Watch CMNP, get fair value alerts →

Compare Citra Marga Nusaphala Persada with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Infrastructure Operations · 60 stocks

Beats the industry median on 11/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 47 · Below median
Fair Value upside +122.8% · Top 25%
Profitability
Return on equity (12 months) 4.7% · Below median
Return on assets 3.9% · Above median
Net margin (12 months) 13.4% · Above median
Operating margin (12 months) 24.6% · Above median
Growth and dividend
Revenue growth (quarter YoY) 71.5% · Top 25%
Balance sheet
Debt / equity 0.41× · Below median

Valuation Multiplesvs Infrastructure Operations median · lower = cheaper

P/E (12 months) 8.8× · Cheapest 25%
P/B 0.54× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 1.22× · Cheaper than median
Price / free cash flow (fiscal year) 9.5× · Cheaper than median
EV/EBITDA 6.7× · Cheaper than median
PEG 0.88× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 47
FUTURE (revenue growth)100 · sector 3
PAST (return on equity)19 · sector 24
HEALTH (low debt)80 · sector 68
DIVIDEND (yield)0 · sector 82

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Infrastructure Operations stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Citra Marga Nusaphala Persada: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Citra Marga Nusaphala Persada Fair Value". https://www.fairvalue-calculator.com/stock/CMNP

Frequently asked questions

Is Citra Marga Nusaphala Persada (CMNP) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of 2,818 IDR versus a price of 1,265 IDR, about +123% upside (undervalued).
What is the fair value of CMNP?
Our model-based fair value for Citra Marga Nusaphala Persada is 2,818 IDR (as of Nov 5, 2026), built from audited fundamentals. The current price: 1,265 IDR.
What is the quality score of CMNP?
Citra Marga Nusaphala Persada has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Citra Marga Nusaphala Persada (CMNP)?
Our model-based price target is the fair value of 2,818 IDR (as of Nov 5, 2026) from 22 valuation models. Cautious scenario 1,297 IDR, optimistic scenario 4,326 IDR. It is a calculation from audited fundamentals, not an analyst target.
What is the Citra Marga Nusaphala Persada stock forecast for 2026?
Our models put fair value at 2,818 IDR, about +123% upside versus a price of 1,265 IDR (undervalued). Cautious scenario 1,297 IDR, optimistic scenario 4,326 IDR. The calculation is refreshed regularly with new filings.
What is the revenue of Citra Marga Nusaphala Persada (CMNP)?
Citra Marga Nusaphala Persada reported trailing-twelve-month revenue of about 6.5T IDR (latest available figure, as of Nov 5, 2026).
What growth is priced into Citra Marga Nusaphala Persada (CMNP)?
For today's price to be fair in a discounted-cash-flow model, Citra Marga Nusaphala Persada would have to grow free cash flow by +9.5 % per year for five years (discount rate 12.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +17.5 % per year. As of Nov 5, 2026.
What discount rate (WACC) does the fair value of CMNP use?
Our models discount Citra Marga Nusaphala Persada at 12.0 %: a base by market capitalisation (small), damped by beta 0.01, country premium for Indonesia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Citra Marga Nusaphala Persada that is +9.5 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (12.0 %) and the same formula as our fair value.
How much growth has Citra Marga Nusaphala Persada (CMNP) delivered so far?
Over the past 5 years revenue at Citra Marga Nusaphala Persada grew +17.5 % a year. The price currently implies free-cash-flow growth of +9.5 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Citra Marga Nusaphala Persada (CMNP) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into Citra Marga Nusaphala Persada (+9.5 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Citra Marga Nusaphala Persada (CMNP)?
The free-cash-flow yield on the price is 10.52 %: that much free cash flow Citra Marga Nusaphala Persada produces per unit of market value. When it exceeds the discount rate of our models (12.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Citra Marga Nusaphala Persada (CMNP)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Citra Marga Nusaphala Persada it is 2,818 IDR per share (as of Nov 5, 2026), against a price of 1,265 IDR. It is the blended result of 22 valuation models in 6 families (DCF Models, Earnings-Based, Multiples, Growth DCF, Economic Profit, Growth Earnings).
Is Citra Marga Nusaphala Persada stock overvalued or undervalued in 2026?
As of Nov 5, 2026, CMNP trades below its calculated fair value: price 1,265 IDR, fair value 2,818 IDR, a gap of about +123% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CMNP?
No. The price is what the market pays today (1,265 IDR); the fair value is what the company's own numbers justify (2,818 IDR). For Citra Marga Nusaphala Persada the two are 1,553 IDR per share apart. That gap is exactly why we show both numbers side by side.
How much is Citra Marga Nusaphala Persada worth?
The market values Citra Marga Nusaphala Persada at about 8.0T IDR (market capitalisation, as of Nov 5, 2026). Per share that is 1,265 IDR; our models calculate a fair value of 2,818 IDR per share.
What do the bullish and bearish scenarios say about CMNP?
Our models span a range for Citra Marga Nusaphala Persada: cautious scenario 1,297 IDR, base 2,818 IDR, optimistic 4,326 IDR per share (as of Nov 5, 2026, price 1,265 IDR). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CMNP?
Citra Marga Nusaphala Persada trades at a price-to-earnings ratio of 8.8 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 2,818 IDR is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2017 to 2025), reported earnings: 8.9. Other multiples: PEG 0.9, P/B 0.5, P/S 1.2, EV/EBITDA 6.7.
What is the PEG ratio of CMNP?
The PEG ratio of Citra Marga Nusaphala Persada is 0.88 (P/E divided by earnings growth, as of Nov 5, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of Citra Marga Nusaphala Persada (CMNP)?
Balance-sheet figures for Citra Marga Nusaphala Persada (as of Nov 5, 2026): return on equity 4.7%, debt of 0.41 per unit of equity. They feed the Quality Score of 47/100, which measures business quality independently of the share price.
How far is CMNP from its 52-week high?
Citra Marga Nusaphala Persada trades at 1,265 IDR, about 35% below its 52-week high of 1,950 IDR and 1% above the low of 1,255 IDR (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 2,818 IDR is for.
Which stocks are comparable to Citra Marga Nusaphala Persada?
From the same area (Industrials) we also value Transurban Group, China Merchants Expressway Network & Technology Holdings, Jiangsu Expressway Company, Shandong Hi-speed Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Citra Marga Nusaphala Persada stock attractive at the current price?
The data as of Nov 5, 2026: price 1,265 IDR, calculated fair value 2,818 IDR (+123%), Quality Score 47/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CMNP calculated?
We run Citra Marga Nusaphala Persada through 22 models from 6 families: DCF Models, Earnings-Based, Multiples, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 2,818 IDR builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. Citra Marga Nusaphala Persada currently trades 55% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Citra Marga Nusaphala Persada (CMNP)?
The closing price on Nov 6, 2026 was 1,265 IDR. Our model-based fair value is 2,818 IDR, about +123% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Citra Marga Nusaphala Persada right now?
The large discount to fair value meets weak quality (47/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (1,297 IDR). The market is more pessimistic than our downside scenario. The model range is unusually wide (1,297 IDR to 4,326 IDR). The outcome hinges heavily on assumptions, so read the point estimate with caution. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Where does the earnings growth of Citra Marga Nusaphala Persada (CMNP) come from?
Earnings per share at Citra Marga Nusaphala Persada grew +4.2 % a year from 2014 to 2025. Broken into its drivers: revenue per share +8.9 %, EBIT margin −1.1 %, tax rate −0.4 %, residual (interest, one-offs) −2.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Citra Marga Nusaphala Persada

How large is the market capitalisation of Citra Marga Nusaphala Persada (CMNP)?
The market capitalisation of Citra Marga Nusaphala Persada is 8.0T IDR (≈ $442M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Citra Marga Nusaphala Persada (CMNP)?
The price-to-sales ratio of Citra Marga Nusaphala Persada is 1.22 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Citra Marga Nusaphala Persada (CMNP)?
Earnings per share at Citra Marga Nusaphala Persada are 143.00 IDR (price ÷ EPS = P/E 8.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Citra Marga Nusaphala Persada (CMNP)?
The net margin of Citra Marga Nusaphala Persada is 13.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Citra Marga Nusaphala Persada (CMNP)?
The return on equity (ROE) of Citra Marga Nusaphala Persada is 4.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Citra Marga Nusaphala Persada (CMNP)?
On an EBIT basis the return on assets of Citra Marga Nusaphala Persada is 6.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Citra Marga Nusaphala Persada (CMNP)?
The operating margin of Citra Marga Nusaphala Persada is 24.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Citra Marga Nusaphala Persada (CMNP)?
Revenue at Citra Marga Nusaphala Persada is growing +71.5% versus a year earlier (3y avg +9.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Citra Marga Nusaphala Persada (CMNP)?
Earnings per share at Citra Marga Nusaphala Persada are growing −69.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Citra Marga Nusaphala Persada (CMNP) carry?
The net debt of Citra Marga Nusaphala Persada is 5.8T IDR (fiscal year 2025, ≈ 6.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Citra Marga Nusaphala Persada in the live analysis

One click puts Citra Marga Nusaphala Persada on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.